Close Menu

marketing agreement

Abbott will be the exclusive distributor of the KIF6 test in the European Union and other areas that recognize the CE mark.

Waters expects the deal to result in its products being offered to a broader use base.

ARUP will begin offering the test, which measures 25 common SNPs associated with prostate cancer risk, in the fall.

Thermo Fisher's sample handling and mass spectrometers will be integrated with IBI's proprietary immunoenrichment technology, and the two firms will develop assays and workflows for the detecting and quantifying low abundance proteins.

Percorso will commercialize Generation Biotech's bead-based haplotype- and region-specific extraction technology.

Promega will sell a combined offering of kinase profiling tools from the two firms.

The firms are working on infectious disease diagnostics using Protagen's UNIarray platform.

RainDance's Sequence Enrichment application enhances SeqWright's targeted resequencing and whole-genome sequencing capabilities for studying disease pathways, cancer, and other areas of research, SeqWright said.

The agreement formalizes a marketing partnership with GeneDiagnostics to sell the ColonSentry test in certain parts of China.

Starting next month, PGXL and Generation Health will provide pharmacogenetic testing and diagnostic services to patients through healthcare providers.

Pages

The New York Times looks at companies using genomic tools to try to quickly identify the cause of patients' infections.

The White House has asked for $2.5 billion in funding to address the COVID-19 outbreak, according to the Associated Press.

A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.

In PNAS this week: immune responses that affect heart transplant rejection risk, gene variants associated with thiopurine toxicity, and more.